DE | EN

Latest Reports

Q1 Report 2012
(PDF)

Latest News

05/16/2012
VITA 34 strengthens biotechnology sector by company takeover and announces change in management board + read

VITA 34 AG

VITA 34 was founded in 1997 as the first private umbilical cord blood bank in Europe. VITA 34 has been focusing on the long-term storage of umbilical cord blood and the production of stem cell transplants of the highest quality and safety. The aim is to develop into a leading provider of cell products in the field of regenerative medicine. With multiple subsidiaries or partners VITA 34 is employed outside Germany, eg Spain, Italy, Austria, Switzerland, Slovenia and Slovakia.

to top